We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnite Regulatory News (UTG)

Share Price Information for Unite (UTG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 932.00
Bid: 931.00
Ask: 932.00
Change: 15.00 (1.64%)
Spread: 1.00 (0.107%)
Open: 916.50
High: 937.00
Low: 915.00
Prev. Close: 917.00
UTG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing

21 Feb 2018 14:39

RNS Number : 5581F
Unite Group PLC
21 February 2018
 

21 February 2018

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE.

 

THE UNITE GROUP PLC

 

RESULTS OF PLACING

 

The Unite Group plc ("Unite Students", or "Unite" or the "Company" or the "Group"), the UK's largest and most established manager and developer of purpose-built student accommodation, is pleased to announce the successful completion of the placing announced earlier today (the "Placing").

A total of 22,206,872 new ordinary shares in the Company (the "Placing Shares") have been placed by J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove" or "JPMC") and Numis Securities Limited ("Numis") (together, the "Joint Bookrunners") at a price of 765 pence per Placing Share, with existing and new institutional investors, raising gross proceeds of approximately £170 million. The placing price of 765 pence per Placing Share represents a discount of 1.7 per cent. to the intra-day price at 2:17 p.m. (being the time the placing price was agreed). The net placing price of approximately 750 pence per Placing Share to be received by the Company after expenses directly attributable to the Placing represents a discount of approximately 3.6% per cent. to that intra-day price.

The Placing Shares represent approximately 9.2 per cent. of the issued ordinary share capital of the Company prior to the Placing.

Application has been made to the Financial Conduct Authority for admission of the Placing Shares to the premium listing segment of the Official List maintained by the UK Listing Authority and to the London Stock Exchange (the "LSE") for admission to trading of the Placing Shares on the LSE's main market for listed securities (together "Admission"). It is expected that Admission will take place at or around 8.00 a.m. (London time) on 23 February 2018 (or such later date as may be agreed between the Company and the Joint Bookrunners) and that dealings in the Placing Shares will commence at the same time.

The Placing Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing issued Ordinary Shares. This includes the right to receive all dividends and other distributions declared or paid in respect of such Ordinary Shares after the date of issue of the Placing Shares. The Placing Shares will be entitled to the final dividend for the year ended 31 December 2017.

Capitalised terms used but not defined in this announcement have the same meanings as set out in the placing announcement of the Company released at 7.00am (London time) today, 21 February 2018.

Richard Smith, Chief Executive Officer of Unite Group, commented:

"We are delighted to have successfully completed this placing and for the strong support received from shareholders. The funds raised will enable us to enhance the growth in earnings from our new University partnerships, whilst maintaining our balance sheet strength. We continue to focus on delivering value for shareholders."

 

The person responsible for making this Announcement on behalf of the Company is Chris Szpojnarowicz, Company Secretary.

 

For further information, please contact:

 

The Unite Group

Richard Smith, Chief Executive Officer

Joe Lister, Chief Financial Officer

0117 302 7045

J.P. Morgan Cazenove (Joint Bookrunner)

Bronson Albery

Barry Meyers

Edouard Asselin

 

0207 742 4000

Numis Securities (Joint Bookrunner)

Heraclis Economides

Ben Stoop

Oliver Hardy

 

 

020 7260 1000

Powerscourt (PR adviser to Unite)

Justin Griffiths

Alison Watson

Mazar Masud

 

020 7250 1446

IMPORTANT NOTICES

 

The distribution of this Announcement and the offering, placing and/or issue of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company, the Joint Bookrunners or any of their respective affiliates that would permit an offer of the Placing Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company and the Joint Bookrunners to inform themselves about and to observe any such restrictions.

This Announcement is for information purposes only and shall not constitute an offer to sell or issue or the solicitation of an offer to buy, subscribe for or otherwise acquire securities in any jurisdiction in which any such offer or solicitation would be unlawful. Any failure to comply with this restriction may constitute a violation of the securities laws of such jurisdictions.

This Announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States (including its territories and possessions, any state of the United States and the District of Columbia (the "United States" or "US"), Canada, Australia, South Africa, Japan or any other jurisdiction in which the same would be unlawful. No public offering of the Placing Shares is being made in any such jurisdiction.

The Placing Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act""), or under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly the Placing Shares may not be offered, sold, pledged or transferred, directly or indirectly, in, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any relevant state or jurisdiction of the United States. There is no intention to register any portion of the offering in the United States or to conduct a public offering of securities in the United States.

The Placing Shares have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of this Announcement. Any representation to the contrary is a criminal offence in the United States.

This Announcement may contain and the Company may make verbal statements containing "forward-looking statements" with respect to certain of the Company's plans and its current goals and expectations relating to its future financial condition, performance, strategic initiatives, objectives and results. Forward-looking statements sometimes use words such as "aim", "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "seek", "may", "could", "outlook" or other words of similar meaning. By their nature, all forward-looking statements involve risk and uncertainty because they relate to future events and circumstances which are beyond the control of the Company, including amongst other things, domestic and global economic business conditions, market-related risks such as fluctuations in interest rates and exchange rates, the policies and actions of governmental and regulatory authorities, the effect of competition, inflation, deflation, the timing effect and other uncertainties of future acquisitions or combinations within relevant industries, the effect of tax and other legislation and other regulations in the jurisdictions in which the Company and its respective affiliates operate, the effect of volatility in the equity, capital and credit markets on the Company's profitability and ability to access capital and credit, a decline in the Company's credit ratings; the effect of operational risks; and the loss of key personnel. As a result, the actual future financial condition, performance and results of the Company may differ materially from the plans, goals and expectations set forth in any forward-looking statements. Any forward-looking statements made in this Announcement by or on behalf of the Company speak only as of the date they are made. Except as required by applicable law or regulation, the Company expressly disclaims any obligation or undertaking to publish any updates or revisions to any forward-looking statements contained in this Announcement to reflect any changes in the Company's expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

No statement in this Announcement is intended to be a profit forecast, and no statement in this Announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.

J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove, and which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority (the "FCA") and the Prudential Regulation Authority, is acting for the Company in connection with the Placing and no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Securities plc nor for providing advice in relation to the Placing or any other matter referred to in this Announcement.

Numis Securities Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting for the Company in connection with the Placing and no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Numis Securities Limited nor for providing advice in relation to the Placing or any other matter referred to in this Announcement.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Bookrunners or by any of their respective affiliates or their or their respective affiliates' agents, directors, officers and employees, respectively, as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this Announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESEWFLFFASEDE
Date   Source Headline
26th Apr 20246:00 pmRNSHolding(s) in Company
25th Apr 20245:06 pmRNSScrip Reference Share Price & Enhanced Scrip
16th Apr 20241:05 pmRNSHolding(s) in Company
15th Apr 20243:20 pmRNSPublication of Base Listing Particulars
11th Apr 202412:05 pmRNSDirector/PDMR Shareholding
10th Apr 20243:15 pmRNSDirector/PDMR Shareholding
10th Apr 20243:00 pmRNS2023 Annual Report and Notice of AGM
9th Apr 20247:00 amRNSTRADING UPDATE AND Q1 FUND VALUATIONS
28th Mar 20244:00 pmRNSTotal Voting Rights
11th Mar 20248:30 amRNSDirector Declaration
6th Mar 20249:30 amRNSDirector/PDMR Shareholding
29th Feb 20244:52 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
19th Feb 20247:00 amRNSUniversity Joint Venture
31st Jan 20243:30 pmRNSTotal Voting Rights
10th Jan 20249:00 amRNSNotice of Results
9th Jan 20247:00 amRNSTRADING UPDATE AND Q4 FUND VALUATIONS
2nd Jan 202410:00 amRNSTotal Voting Rights
1st Dec 20232:00 pmRNSBlock listing Interim Review
30th Nov 20234:00 pmRNSTotal Voting Rights
16th Nov 20232:00 pmRNSDirector/PDMR Shareholding
31st Oct 20234:30 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSTotal Voting Rights
20th Oct 20232:00 pmRNSResults of Scrip Dividend Election
5th Oct 20237:01 amRNSTrading Update and Q3 Fund Valuations
5th Oct 20237:00 amRNSCEO Succession & Board Changes
2nd Oct 20234:00 pmRNSDirector/PDMR Shareholding
29th Sep 202311:00 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSSCRIP REFERENCE SHARE PRICE-2023 INTERIM DIVIDEND
20th Sep 20232:10 pmRNSHolding(s) in Company
15th Sep 20236:31 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSNew 800-bed development in Glasgow
31st Aug 20232:00 pmRNSTotal Voting Rights
1st Aug 202310:00 amRNSHolding(s) in Company
31st Jul 20233:00 pmRNSTotal Voting Rights
27th Jul 202311:13 amRNSHolding(s) in Company
27th Jul 202311:00 amRNSDirector/PDMR Shareholding
25th Jul 20236:00 pmRNSUnite Group
25th Jul 20237:00 amRNSResults of Capital Raise
24th Jul 20234:41 pmRNSRetail offer of new ordinary shares
24th Jul 20234:40 pmRNSProposed placing of new ordinary shares
24th Jul 20234:38 pmRNSInterim Results
10th Jul 20237:00 amRNSTRADING UPDATE AND Q2 FUND VALUATIONS
30th Jun 20235:10 pmRNSTotal Voting Rights
23rd Jun 20239:00 amRNSNotice of Interim Results
21st Jun 20235:24 pmRNSHolding(s) in Company
16th Jun 20234:30 pmRNSDirector/PDMR Shareholding
12th Jun 20232:30 pmRNSAdditional Listing
1st Jun 20234:00 pmRNSDirector/PDMR Shareholding
1st Jun 202311:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.